News

BBRSC funding for Ghilarov and Uphoff Labs

We are very grateful to BBSRC for this major funding. Between our two labs we will now investigate how bacterial repair exonuclease, ExoVII, is recognising and repairing protein-DNA crosslinks following fluoroquinolone treatment. Fluoroquinolones such as ciprofloxacin remain some of the most prescribed and most effective antibiotics, and it is very important we understand their mechanisms of action
2025-12-22 15:55